The national database of the German Collaborative Arthritis Centres: II. Treatment of patients with rheumatoid arthritis

Annals of the Rheumatic Diseases

Volumn 60, Issue 3, 2001, Pages 207-213

  Zink, A ^a   Listing, J ^a   Niewerth, M ^a   Zeidler, H ^b  

^a German Rheumatism Research Centre   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTIMALARIAL AGENT; ANTIRHEUMATIC AGENT; AZATHIOPRINE; CORTICOSTEROID; GOLD; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; SALAZOSULFAPYRIDINE; STEROID;

ARTICLE; CLINICAL PRACTICE; DATA BASE; DISEASE DURATION; DOSE RESPONSE; DRUG CHOICE; GERMANY; HOSPITAL PATIENT; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; OCCUPATIONAL THERAPY; OUTPATIENT CARE; PRESCRIPTION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ADOLESCENT; ADULT; AMBULATORY CARE; ANTI-INFLAMMATORY AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DATABASES, FACTUAL; DRUG THERAPY, COMBINATION; FEMALE; GERMANY; HUMANS; INTERPROFESSIONAL RELATIONS; LENGTH OF STAY; MALE; METHOTREXATE; MIDDLE AGED; OCCUPATIONAL THERAPY; PATIENT ADMISSION; PATIENT EDUCATION; STEROIDS;

EID: 0035091450     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.60.3.207     Document Type: Article

References (30)

1. Therapy of rheumatoid arthritis: A pyramidal plan
2. Remodeling the pyramid: A concept whose time has come
3. Re-evaluating the therapeutic approach to rheumatoid arthritis: The 'sawtooth' strategy
4. A Canadian survey of current methotrexate prescribing practices in rheumatoid arthritis
5. Combination therapy of rheumatoid arthritis: Rationale and overview
6. Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: A randomised trial
7. The effectiveness of early treatment with 'second line' antirheumatic drugs: A randomized, controlled trial
8. Combination therapy with multiple disease-modifying antirheumatic drugs in rheumatoid arthritis: A preventive strategy
9. Editorial review. Systemic glucocorticoid treatment in rheumatoid arthritis - A debate
10. The case of corticosteroids in the treatment of early rheumatoid arthritis
11. Corticosteroids in rheumatoid arthritis - The case against
12. Guidelines for the management of rheumatoid arthritis
13. The national database of the German Collaborative Arthritis Centres: I. Structure, aims, and patients
14. Differences in the use of second-line agents and prednisone for treatment of rheumatoid arthritis by rheumatologists and non-rheumatologists
15. Epidemiologie der behandlung bei an chronischer polyarthritis erkrankten in Hannover
16. Rheumatoid arthritis: Not yet curable with early intensive therapy
17. Trends in antirheumatic medication use among patients with rheumatoid arthritis, 1981-1996
18. Antirheumatic drug-prescribing behaviour of Australasian rheumatologists
19. Use of second line 'disease modifying' antirheumatic drugs (DMARDs) within 5 months of disease onset by 64% of 750 rheumatoid arthritis patients under care of 142 US rheumatologists: An inception cohort study
20. European and US rheumatologists agree on triple but not on double or single early DMARD choice for different types of RA
21. Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications
22. The changing face of rheumatoid arthritis therapy: Results of serial surveys
23. What explains the variation among rheumatologists in their use of prednisone and second line agents for the treatment of rheumatoid arthritis?
24. Direct and indirect medical costs incurred by Canadian patients with rheumatoid arthritis: A 12 year study
25. Use of second line drugs for the treatment of rheumatoid arthritis in Edmonton, Alberta. Patterns of prescription and longterm effectiveness
26. A multicenter study of hospitalization in rheumatoid arthritis. Frequency, medical-surgical admissions, and charges
27. A multicenter study of hospitalization in rheumatoid arthritis: Effect of health care system, severity, and regional difference
28. Patient outcome following inpatient vs outpatient treatment of rheumatoid arthritis
29. The two-year follow-up of a randomized comparison of in-patient multi-disciplinary team care and routine out-patient care for active rheumatoid arthritis